Find UNII-3QJ8WS6V8H manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

30 RELATED EXCIPIENT COMPANIES

55EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1310-45-8, Ferric subsulfate solution, Basic ferric sulfate, Iron hydroxide sulfate (fe4(oh)2(so4)5), Iron(3+);dihydroxide;pentasulfate, 3qj8ws6v8h
Molecular Formula
Fe4H2O22S5
Molecular Weight
737.7  g/mol
InChI Key
GDPKWKCLDUOTMP-UHFFFAOYSA-B
FDA UNII
3QJ8WS6V8H

UNII-3QJ8WS6V8H
Ferric subsulfate is a stypic or hemostatic agent that causes agglutination of surface proteins resulting in local hemostasis. It has the chemical formula Fe4(OH)2(SO4)5. It is used after superficial skin biopsies.
1 2D Structure

UNII-3QJ8WS6V8H

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
iron(3+);dihydroxide;pentasulfate
2.1.2 InChI
InChI=1S/4Fe.5H2O4S.2H2O/c;;;;5*1-5(2,3)4;;/h;;;;5*(H2,1,2,3,4);2*1H2/q4*+3;;;;;;;/p-12
2.1.3 InChI Key
GDPKWKCLDUOTMP-UHFFFAOYSA-B
2.1.4 Canonical SMILES
[OH-].[OH-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Fe+3].[Fe+3].[Fe+3].[Fe+3]
2.2 Other Identifiers
2.2.1 UNII
3QJ8WS6V8H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ferric Subsulfate Solution

2. Monsel's Solution

2.3.2 Depositor-Supplied Synonyms

1. 1310-45-8

2. Ferric Subsulfate Solution

3. Basic Ferric Sulfate

4. Iron Hydroxide Sulfate (fe4(oh)2(so4)5)

5. Iron(3+);dihydroxide;pentasulfate

6. 3qj8ws6v8h

7. Monsel's Solution

8. Iron Dihydroxide Pentakis(sulphate)

9. Einecs 215-179-2

10. Unii-3qj8ws6v8h

11. Ferric Subsulfate [usp:nf]

12. Iron Hydroxide Sulfate

13. Iron Subsulfate

14. Ferric Subsulphate

15. Ferric Subsulfate (usp)

16. Basic Ferric Sulfate Solution

17. Monsel's Solution [mi]

18. Dtxsid30893846

19. Ferric Subsulfate [vandf]

20. Ferric Subsulphate Solution

21. Ferric Subsulfate [who-dd]

22. Ferric Subsulfate Decahydrate

23. Basic Ferric Sulphate Solution

24. Akos015910508

25. Ferric Subsulfate [usp Impurity]

26. Iron Dihydroxide Pentakis Sulfate

27. Iron(iii) Dihydroxide Pentakis(sulfate)

28. Iron Dihydroxide Pentakis Sulphate

29. Ft-0717042

30. D08921

31. Iron Hydroxide Sulphate (fe4(oh)2(so4)5)

32. Q5445335

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 737.7 g/mol
Molecular Formula Fe4H2O22S5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count22
Rotatable Bond Count0
Exact Mass737.50387 g/mol
Monoisotopic Mass737.50387 g/mol
Topological Polar Surface Area445 Ų
Heavy Atom Count31
Formal Charge0
Complexity62.2
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count11
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Hemostatics

Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)


4.2 FDA Pharmacological Classification
4.2.1 Pharmacological Classes
Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Iron [CS]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Solubilizers

read-more
read-more

Parenteral

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Emulsifying Agents

read-more
read-more

Lubricants & Glidants

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Topical

read-more
read-more

Rheology Modifiers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty